ALB

AI Research

Ketjen sale proceeds $670M → Debt reduction + dividend maintained at $1.62 annualized

Albemarle completed the sale of its controlling stake in Ketjen refining catalyst business to KPS Capital Partners on March 2, receiving $670 million in proceeds for debt reduction and general corporate purposes. The company declared a quarterly dividend of $0.405 per share ($1.62 annualized) while executing a debt tender offer to reduce leverage following the Ketjen and Eurecat sales. With 19 analysts recommending Buy and the stock trading at $164.90 as of March 16, investors view the company's asset optimization strategy favorably, though near-term lithium market weakness poses risks.